Arcellx stock soars 78% as Gilead agrees to $7.8B acquisition
Arcellx stock soars 78% as Gilead agrees to $7.8B acquisitionSource: Investing.com
Arcellx stock soars 78% as Gilead agrees to $7.8B acquisitionSource: Investing.com
Citi remains bullish on stocks amid strong Q4 resultsSource: Investing.com
RBC raises Santander target 44% on cost-cut drive, ROTE outlookSource: Investing.com
Novo Nordisk and Netflix fall premarket; Eli Lilly and Domino’s Pizza riseSource: Investing.com
Own these sectors into restocking cycle after tariff ruling: WFSource: Investing.com
Lupin Gets European Commission Nod for Biosimilar RanibizumabSource: Investing.com
Novo Nordisk shares plunge after obesity drug falls short of rival in trialSource: Investing.com
Is UK housing set for policy-driven upside? Barclays maintains top picksSource: Investing.com
FTSE 100 today: UK stocks edge lower on tariff worries; pound higher over $1.35Source: Investing.com
Jefferies resets software ratings, downgrades 4 stocksSource: Investing.com